In our subgroup analysis, we separate enrolled studies into four groups according to patients' population: all ICU admissions (seven studies), sepsis and shock (two studies), surgical (three studies), trauma (three studies), and others (three studies, one on patients with ALI or ARDS, one on patients with intracerebral hemorrhage, and one on patients with anemia and renal dysfunction).
Table 2 Comparisons of meta-analyses evaluating timing of RRT initiation in AKI and patients outcomes Population setting Enrolled studies Outcomes Results (benefit of early RRT) Limitations Current study Mixed patients with AKI (n = 1627) Total nine RCTs.
The REMARK guidelines, consisting of 20 detailed items, assess several aspects of the enrolled studies, such as study aim, study design, patient enrollment, biomarker detection, statistical analysis method, and report of results.
Owing to the significant heterogeneity among the enrolled studies, we used the random effects model.
Furthermore, in the majority of the enrolled studies, clinical patient care is individualized based on the discretion of the clinician.
In enrolled studies in our meta-analysis, the combination group had studies with higher quality and larger than chlorhexidine alone group.
All enrolled study patients provided their written informed consent for enrolment into the study.
31 patients enrolled, study period 7 days.
Written informed consent was obtained from all enrolled study participants.
SS, CJC, DSB, and KTT enrolled study subjects.
Second, this case-control study enrolled study subjects with and without esophageal cancer identified from 2000 to 2009.
